Learn everything you need to know about Ambroxol-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has started a safety review of medicines that contain ambroxol and bromhexine. The medicines are used as ...

Review the side-effects of Ambroxol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Please provide your email address to receive an email when new articles are posted on . Although a high number of adverse events were logged, most were mild to moderate in severity. The effects of ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes ...

Medicines containing ambroxol or bromhexine carry a small risk for severe skin reactions, which include erythema multiforme and Stevens-Johnson syndrome, and the product labels should be updated to ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia poses a ...

A major trial to test whether a cough medicine will slow down Parkinson’s has been announced. Early studies suggest the drug, called ambroxol, appears to remove damaging proteins from the brain which ...

Ambroxol showed target engagement in Parkinson's dementia but no significant cognitive improvement over placebo. The drug, a common cough medicine in Europe, was safe and well-tolerated. Ambroxol ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests. Nearly half of those diagnosed with Parkinson’s ...